How Timely is Canada’s Medication Review and Approval Process?
Date held: January 24th, 2019
Presented by: Gerry Jeffcott, 3Sixty Public Affairs with Nigel Rawson & Sarah Lussier
This presentation was hosted by Gerry Jeffcott from 3Sixty Public Affairs, who was joined by two pharmaceutical policy researchers who have conducted analyses of Canada’s access performance over time and in comparison with other countries.
The session began with an overview of each of the elements of the Canadian review and approval process by our moderator. After that, the session explored each agency’s performances in terms of supporting efficient access to needed new medicines. We will also compare Canada with other similar countries to determine how we fare internationally in terms of gaining access.
The presentation includes an interactive question and answer session.
The slides will be available on our Slideshare account here.